We recently reported that GFI1 mediates MM cell growth and viability, enhances MM cell resistance to bortezomib-induced cell death in vitro, and increases MM cell growth and osteoclastogenesis in vivo [12]. This evidence concerns the gene GFI1 and Miyoshi myopathy.